Related Experiment Video
Updated: Jul 26, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Acquired hemoglobin H in refractor sideroblastic anemia. A preleukemic marker
Idiopathic refractory sideroblastic anemia (IRSA) patients with acquired hemoglobin H developed leukemia. Those without hemoglobin H did not develop leukemia, suggesting its use in identifying preleukemic patients.
Area of Science:
- Hematology
- Oncology
Background:
- Idiopathic refractory sideroblastic anemia (IRSA) is a rare bone marrow disorder.
- Identifying patients with IRSA who are at high risk for developing acute leukemia is crucial for early intervention.
Observation:
- Two patients with IRSA were diagnosed with acquired hemoglobin H.
- These patients subsequently developed leukemic syndromes.
- Six other IRSA patients with normal hemoglobin electrophoresis did not develop acute leukemia within five years.
Findings:
- Acquired hemoglobin H was observed in a subset of IRSA patients.
- The presence of hemoglobin H in IRSA patients correlated with the development of leukemia.
- Normal hemoglobin electrophoresis patterns in IRSA patients were associated with a lack of leukemia development.
Implications:
- Hemoglobin electrophoresis should be considered a routine diagnostic tool for IRSA patients.
- Detecting acquired hemoglobin H may help distinguish preleukemic IRSA patients.
- This finding could lead to improved risk stratification and personalized treatment strategies for IRSA.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018